Abstract

BackgroundPatients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) often develop hypertension in childhood or early adulthood. Although this could result in left ventricular hypertrophy (LVH), a major risk factor for cardiovascular morbidity and mortality, prior studies of LVH in ADPKD have yielded conflicting results. We estimated the prevalence of LVH using consensus echocardiography criteria and examined the independent association of ADPKD severity with LV mass in a contemporary cohort of ADPKD patients.MethodsAdults with ADPKD and eGFR> 15 ml/min/1.73m2 were enrolled in a single-center study. Left Ventricular Mass (LVM) was quantified using 2D echocardiography, and LVH was defined using gender-specific cut-points of LVM and LVM indexed to body surface area (LVMI) from consensus guidelines. Total Kidney Volume (TKV) was quantified using Magnetic Resonance Imaging, and GFR was estimated from serum creatinine using the CKD-Epi equation. Multiple linear regression was used to estimate the association of TKV and eGFR with LVM and LVMI, adjusting for potential confounders.ResultsAmong 126 participants (78% with hypertension), median age was 46 years, median eGFR 63 ml/min/1.73 m2, and median [IQR] systolic blood pressure was 125 [116–133] mmHg. Prevalence of LVH was 21.4% as defined by LVMI and was not significantly different (p = 0.8) between those with and without HTN, and was similar (21.4%) after excluding those (N = 21) with known cardiac disease. Greater TKV and lower eGFR were directly correlated with greater LVMI (p = .016 and p < .001, respectively). In multiple linear regression models accounting for potential confounders including blood pressure, greater TKV was positively associated with LVM ( hat{beta} =0.19, p = 0.04).ConclusionsIn a contemporary cohort of ADPKD patients with well-controlled blood pressure, the prevalence of LVH is high, and ADPKD severity as reflected by TKV is independently associated with greater LV mass. These results may suggest a relationship between ADPKD pathophysiology and increased LV mass.

Highlights

  • Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) often develop hypertension in childhood or early adulthood

  • Conflicting and inconclusive results have led to a lack of consensus on whether ADPKD patients are at increased risk of left ventricular hypertrophy (LVH), and whether the risk of LVH has decreased along with improved BP management

  • We examined the prevalence of LVH among a cohort of adults with ADPKD using echocardiography, defining LVH with contemporary guidelines and normative data

Read more

Summary

Introduction

Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) often develop hypertension in childhood or early adulthood. This could result in left ventricular hypertrophy (LVH), a major risk factor for cardiovascular morbidity and mortality, prior studies of LVH in ADPKD have yielded conflicting results. Hypertension is a highly prevalent and often early manifestation of autosomal dominant polycystic kidney disease (ADPKD), and a major risk factor for cardiovascular morbidity and mortality [1, 2]. Increased left ventricular mass (LVM) and the development of left ventricular hypertrophy (LVH) are consequences of long-standing hypertension and strong predictors for risk of cardiovascular morbidity and mortality in the general population [4]. Conflicting and inconclusive results have led to a lack of consensus on whether ADPKD patients are at increased risk of LVH, and whether the risk of LVH has decreased along with improved BP management.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call